Novo Nordisk A/S (ETR:NOV)
Germany · Delayed Price · Currency is EUR 39.88
-0.48 (-1.18%)
Nov 7, 2025, 10:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of €173.33 billion as of November 7, 2025. Its market cap has decreased by -63.59% in one year.
Market Cap
173.33B
Enterprise Value
182.52B
Revenue
42.26B
Ranking
n/a
PE Ratio
12.47
Stock Price
€39.88
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 6.23B to 173.33B, an increase of 2,683.66%. That is a compound annual growth rate of 12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 173.33B | -53.39% |
| Dec 30, 2024 | 371.85B | -10.95% |
| Dec 29, 2023 | 417.56B | 46.59% |
| Dec 30, 2022 | 284.85B | 26.44% |
| Dec 30, 2021 | 225.29B | 69.93% |
| Dec 30, 2020 | 132.58B | 8.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 49.28B |
| Merck KGaA | 47.96B |
| Fresenius SE & Co. KGaA | 26.83B |
| Bayer Aktiengesellschaft | 25.60B |
| Sartorius Aktiengesellschaft | 13.70B |
| Fresenius Medical Care AG | 12.17B |
| Fielmann Group AG | 3.72B |
| Carl Zeiss Meditec AG | 3.66B |